 |
 |
|
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
| |
| | |
|
|
|
|
|
|
Guide for Authors
Diagnostic Microbiology and Infectious Disease
Instructions to Authors
As of 01 June 2005, all new manuscripts
must be submitted through theDiagnostic Microbiology and Infectious Disease online submission and review
Web site ( http://ees.elsevier.com/dmid/
). Authors are requested to submit
the text, tables, and artwork in electronic form (not as a PDF ) to this address. In an accompanying
letter, authors should state that the manuscript, or parts of it, have
not been and will not be submitted elsewhere for publication.
Authors are
highly encouraged to include a list of three or more potential reviewers for
their manuscript, with complete contact information.
Submission items include a cover letter (save as a separate file for upload), suggested reviewers, the
manuscript (including title page,
abstract, manuscript text, references, and
table/figure legends), tables, and figures. Revised manuscripts should also be
accompanied
by a unique file (separate from the covering letter) with responses
to reviewers' comments. The preferred order of files is as follows:
cover letter,
suggested reviewers, response to reviews (revised manuscripts only), manuscript file(s), table(s),
figure(s). Files should
be labeled with appropriate and descriptive file names
(e.g., SmithText.doc, Fig1.eps, Tables3.doc). Upload text, tables and graphics
as separate files. (You can compress multiple figure files into a Zip file and upload that in one step; the system will then unpack the
files and prompt you to name each figure.) Do not import figures or tables into the text document and do not upload your text as a
PDF.
Complete instructions for electronic artwork submission can be found on the
Author Gateway, accessible through the journal home
page. Your figures will be tested by an artwork quality check tool; you will be asked to view the results before you can complete your
submission. Your figures can move into review if not up to production standards, but you should be prepared to provide better quality
figures should we express interest in your manuscript.
Authors who are unable to provide an electronic version or have other
circumstances
that prevent online submission must contact the Editors
prior to submission to discuss alternate options. The Publisher and
Editors regret
that they are not able to consider submissions that do not
follow these procedures.
Please note, although the Elsevier Editorial System
Registration page asks if you are available for reviews, we are not currently seeking new reviewers as members of the Editorial Board.
All other correspondence should be addressed to the Editor in Chief:
Ronald N. Jones, M.D., Editorial Office, Diagnostic Microbiology
and Infectious
Disease, Suite A, 345 Beaver Kreek Centre, North Liberty, Iowa 52317, USA.
Manuscripts
Papers may
be submitted that are full-length articles (including subject review articles), or
short notes. Manuscripts are accepted with the understanding
that they are original, unpublished
work and are not being submitted elsewhere. All manuscripts are subjected to peer review by the
editors, by members of the Editorial Board, or by other qualified reviewers.
Papers must be accompanied by a letter signed by the
corresponding author indicating that
they have read and are familiar with the current "Instructions to Authors" (published in
each issue)
and will comply with the instructions and stated conditions. The letter should indicate
that all of the named authors and acknowledged
parties have agreed to the submitted draft of the
paper or, as providers of personal communications, have consented to their inclusion,
and that the
content/submission is original/unpublished and has not been simultaneously submitted to another
medical journal. Furthermore,
previous or other publication of any or part of the content of the
manuscript (including conference or congress proceedings, letters,
and brief communications)
must be declared on the title page. Failure to comply with the above mentioned policies may
result in a 3-year
suspension of publishing privileges in this journal.
Manuscripts should be submitted via the Elsevier
Editorial System, in English, double-spaced, and, where appropriate, divided into Introduction; Materials and Methods,
which should include sufficient technical information so that experiments can be repeated and
which should give sources of unusual chemicals,
reagents, equipment, or microbial strains;Results, which should describe the design of the experiments as well as the results
using text, tables, or figures; and Discussion, which should provide an interpretation of
the results in relation to previously
published work. An abstract is required for all
papers; it should be 150 words or less for full-length papers and 50 words
or less for notes.
Papers for the Notes category, which is intended for the presentation of brief observations
(including instructive
case reports), that do not warrant full-length papers, should not contain anysection heading and should not exceed 1,000 words.
The
first page of the manuscript should include: title, running title of not more than 45
characters and spaces, full names of all authors,
address of the institution at which the work was
performed, and the corresponding author's full address, telephone number, and FAX number.
Any change of address by any of the authors should also be noted. Any footnotes to the text
should be numbered using Arabic numerals
and should be typed on the page of the manuscript on
which they are referred to.
Tables
Tables should be on separate
files and numbered using Arabic numerals. Each table
should have a brief title with detailed information appearing as footnotes bearing
superscript,
lower-case letters. Vertical rules should be avoided.
References
References should be arranged in alphabetical
order. In the text they should be referred to by
name and year. If there are more than two authors, use the name of the first author
followed by et
al. Papers by the same author(s) published in the same year should be distinguished by the use of
lowercase letters following
the date. References should contain the following, in the order
shown: names of all contributing authors (last names first); date of
publication; title of article; title
of journal (abbreviate according to the style of Index Medicus) or book; volume
number,
location and name of publishing company (books only); and inclusive pages. Example:
Journal. Owen DAA, Lynch JM (1975)
The effects of histamine and some
histamine-like agonists on blood pressure. Br J Pharmacol 55:171-173.
Edited
Book. Redei A, Kelemen P (1969) The presence of platelets in acute
oedema. In Inflammation Biochemistry. Eds, A Bertelli
and JC Houck. Amsterdam:
Elsevier, pp 161-165.
Figures
All manuscripts must be accompanied by complete artwork. Each
figure must be on a separate file. Electron micrographs should be
of sufficient contrast to withstand reduction and printing at the journal
page size. The cost of
printing color photographs must be borne by the author. Any graphs, charts, or diagrams should
be finished drawings,
using type size large enough to be read easily when reduced to page size.
Proofs and Reprints
The corresponding author
will receive page proofs, which should be corrected and returned
within 48 hours of receipt. Corrections are limited to printer's errors
and no substantial author's changes will be made. Reprints may be ordered at the price listed on
the order form accompanying the proofs.
Style and Nomenclature
Authors should use the CBE (Council of Biology Editors) Style
Manual, 5th
ed., as a general guide for style. The names of chemical compounds should
conform with Chemical Abstracts and its indexes
or The Merck Index,
11th ed. Enzymes and biochemical terms should bear the recommended, trivial name listed in the
latest
edition of Enzyme Nomenclature. Whenever possible, use generic drug names.
Binary names consisting of a generic name and a
species name must be used for all
microorganisms. Names of general and higher categories may be used alone. However, a species
name
must be preceded by the complete generic name the first time that it is used in the
manuscript. Following this, the generic name should
be abbreviated to the initial capital letter (for
example, S. aureus), provided there can be no confusion with other genera
of
organisms used in the paper. The nomenclature for bacteria should follow well-established references such as Bergey's Manual
of Determinative Bacteriology (current edition) or the Manual of Clinical Microbiology, 8th ed., or validation lists and
specific articles published in the International Journal of Systematic and Evolutionary Microbiology since January 1, 1989.
Informative web sites are available as well ( http://www.dsmz.de/bactnom/bactname.htm and http://www.bacterio.cict.fr
).
Nomenclature and classifications of fungi and yeasts are the responsibility of the manuscript authors as guided by published sources
such as Ainsworth and Bisby's Dictionary of the Fungi, 9th ed. (2001) and The Yeasts: A Taxonomic Study, 4th ed. (1998).
Names used for viruses should be those listed in the International Committee on Taxonomy of Viruses publication (Virus Taxonomy:
Classification and Nomenclature of Viruses: Seventh Report of the International Committee of Taxonomy and Viruses, 2000). Synonyms
may be used in parentheses when the name is first used in conjunction with the approved generic (or group) and family names.
Copyright
Upon acceptance of an article by the journal, the author(s) will be asked to transfer copyright
of the article to the publisher.
This transfer will insure the widest possible dissemination of
information under the US copyright law. Unless this agreement is executed,
the journal will not
publish the manuscript.
Updated July 2008
|
|
|
|
| |
| | |
|
| |
